{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-104942","form_type":"8-K","ticker":"ISPC","cik":"0001558569","company_name":"iSpecimen Inc.","filed_at":"2025-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.732864+00:00","generated_at":"2026-05-17T00:52:18.166642+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"iSpecimen stockholders approve reverse stock split, authorized share increase, and equity line of credit","bullets":["Reverse stock split approved at ratio from 1:10 to 1:100; Board to set exact ratio.","Authorized shares increased from 250M to 1B; 1,370,770 voted for.","Private financings up to >19.99% of shares at sub-minimum price approved for Nasdaq compliance.","Convertible securities amended to raise conversion price floor from 50% to 80% of lowest VWAP.","Equity line of credit approved allowing issuance >19.99% of shares at below-minimum price."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-104942","json":"https://secwatch.observer/filing/0001213900-25-104942.json","markdown":"https://secwatch.observer/filing/0001213900-25-104942.md","text":"https://secwatch.observer/filing/0001213900-25-104942.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1558569/000121390025104942/0001213900-25-104942-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1558569/000121390025104942/ea0263543-8k_ispecimen.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:52:18.166642+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}